Skip to content

Planning 01.01 · Feasibility & Strategy

Define the Right Project Before Designing It.

The study converts a product portfolio and target markets into a facility concept that can be costed and compared. Capacity, dosage forms, site options and regulatory targets are assessed together. The result is a recommendation with CAPEX/OPEX ranges, key risks and a realistic schedule.

Engineering phases

Where this service fits

02 / 09 phases in scope

  1. 01FeasibilityIn scope
  2. 02ConceptIn scope
  3. 03Basic Engineeringnot in scope
  4. 04Detailed Engineeringnot in scope
  5. 05Procurementnot in scope
  6. 06Constructionnot in scope
  7. 07Commissioningnot in scope
  8. 08Validationnot in scope
  9. 09Operationnot in scope

Scope

What the service covers

  1. 01Product portfolio and capacity analysis
  2. 02Site selection and existing-building assessment
  3. 03Regulatory pathway and target-market review
  4. 04CAPEX/OPEX estimation and phasing options
  5. 05Risk register and investment decision support

Method

From inputs to deliverables

INInputs

05 items
  1. I01Product portfolio and dosage forms
  2. I02Target markets and forecast volumes
  3. I03Candidate sites or existing buildings
  4. I04Investment horizon and budget envelope
  5. I05Known regulatory targets

WORKActivities

06 items
  1. W01Capacity and shift-pattern modeling
  2. W02Site and building assessment
  3. W03Regulatory pathway review
  4. W04Option development and comparison
  5. W05CAPEX/OPEX range estimation
  6. W06Risk identification and phasing analysis

OUTDeliverables

04 items
  1. D-01.01.01Feasibility report with CAPEX/OPEX ranges
  2. D-01.01.02Capacity and batch-size model
  3. D-01.01.03Site evaluation matrix
  4. D-01.01.04Preliminary project schedule and risk register

Technical detail

What the study examines

  • Capacity is derived from the products, not assumed from a floor area.

    • Dosage forms and product families
    • Annual volumes and batch sizes
    • Shift patterns and equipment utilization
    • Campaign versus dedicated manufacturing
    • Growth scenarios and reserved capacity

Deliverables

Typical documents and outputs

  1. D-01.01.01Feasibility report with CAPEX/OPEX ranges
  2. D-01.01.02Capacity and batch-size model
  3. D-01.01.03Site evaluation matrix
  4. D-01.01.04Preliminary project schedule and risk register

Services

Related services

  • 01.02

    Master Planning & Concept Engineering

    Zoning, flows and phasing fixed early, while changes are still inexpensive.

  • 04.04

    Project Management

    One point of control for scope, cost, schedule and interfaces.

  • 04.01

    GMP & Compliance

    Facility design reviewed against GMP requirements at every stage.

FAQ

Questions about this service

  • Design starts from the product portfolio and dosage forms, whether the scope includes sterile, nonsterile, or hazardous-drug activities, the expected capacity and shift pattern, the site or existing building, available utilities, the target markets and their regulatory framework, and the intended schedule and budget range. A short description is enough to begin; existing studies, layouts, or a project brief help define a more precise scope.

Next step

Planning a pharmaceutical project?

Share the product type, the current stage and the main constraints. We will respond with a proposed scope and next steps.

+20 101 171 1700